News and Articles

Healthcare providers play a vital role in supporting individuals living with diabetes manage a complex condition. The Canadian Medical Association Journal (CMAJ) recently highlighted five evidence-informed strategies to help tailor...

As of July 31, 2025, Dexcom G7 sensors and receivers will be officially listed under the Ontario Drug Benefit (ODB) program. This milestone expands access to real-time continuous glucose monitoring...

Diabetes Canada's March 2025 Clinical Practice Guidelines now recommend that all individuals living with type 1 diabetes (T1D) should use Automated Insulin Delivery (AID) systems, provided they are willing and...

The government-funded Saskatchewan Extended Benefits and Drug Plan has expanded coverage for real-time continuous glucose monitoring (rtCGM) systems. Newly included are the following groups of people who use insulin: People...

Dexcom has partnered with RxFood in supporting individuals living with diabetes by offering an integrated solution that combines industry-leading glucose monitoring system with an AI-powered nutrition app. This collaboration enables...

A recent clinical study 1 demonstrated that real-time continuous glucose monitoring (rtCGM) systems, like Dexcom G7, can offer substantial benefits to people living with type 2 diabetes (T2D) who are...